Jordyn Taylor of Beta Beat reports, "In case you needed more proof that all our jobs will one day be occupied by robots, a Hong Kong V.C. firm has just named an artificial intelligence tool to its board of directors. The company’s also insisting the tool will be treated as an 'equal' to the other board members. Sure, it’s all probably a bid for press — but it’s still pretty funny."
Taylor continues, "A press release from Aging Analytics UK, a company that conducts research on biotechnology and regenerative medicine, made two announcements this morning: first, that they’ve launched an new A.I. tool called VITAL (Validating Investment Tool for Advancing Life Sciences); and second, that they’ve licensed VITAL to Hong Kong V.C. firm Deep Knowledge Ventures, where the tool will become an 'equal member of its Board of Directors.' Yes, that means it’ll have exactly the same power as a living, breathing, presumably college-educated human being."
Taylor adds, "VITAL uses machine learning to predict which life science companies will make for successful investments, the press release explains. That’s why it’ll be of use to Deep Knowledge Ventures, which 'routinely invest[s] in both private and public companies specializing in biotechnology, regenerative medicine, oncology, drug discovery, bioinformatics and personalized medicine,' according to their website."
Image: Courtesy Flickr/ epSos.de